IXICO PLC (LSE:IXI) - Overview

Stock Report

IXICO PLC IXI

Last Price
GBX43.50

Day Change
6.00|16.00%

As of 02/12/2016
16:00:57 GMT | GBX
Minimum 15 Minutes Delay.

Last Close37.50p
Day Range38.00 - 44.00
Mkt Cap11.52Mil
52-Wk Range22.00 - 44.00
Yield %0.00
ISINGB00BCLY7L40
Volume71,061
P/E-6.11
P/S2.10
P/CF-4.98

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
IXICO PLC79.38 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover-2.563.12
Operating Profit--1.89-1.39
Net Profit--1.72-1.19
Reported EPS--11.39-7.90
Balance Sheet
Current Assets-4.773.82
Non Current Assets-0.640.42
Total Assets-5.414.24
Current Liabilities-1.501.47
Total Liabilities-1.601.53
Total Equity-3.812.71
Cash Flow
Operating Cash Flow--2.15-1.63
Net Change in Cash-1.83-1.36
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
2016-0.77-4.10--10.61---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
26/09/2016Exercise of OptionProf Derek Hill1.0029,773298.00
01/03/2016PurchaseMs. Susan Lowther35.2528,3669,999.00
04/02/2016PurchaseProf Derek Hill33.6810,0003,368.00
03/02/2016PurchaseDr. Andy Richards32.6845,89915,000.00

Company Profile

IXICO PLC is a medical technology and diagnostics company. It provides clinical trials services to the global pharmaceutical industry. It is engaged in researching, diagnosing and treating serious diseases.
 

Sector

Biotechnology

Market Position

1476 of 1865 Companies

Index

FTSE AIM All Share

Outlook

(07/06/2016) no outlook statement

Next Event 09/01/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)0.0013.1416.27
Div Yld (E)0.004.184.36
PEG (E)0.000.360.00
ROCE-51.56206.9680.66
Op Mrgn-40.90-17.09-14.86
EPS Grwth0.009.6525.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Charles Spicer
Chief Executive OfficerProf Derek Hill
Chief Financial OfficerMs. Susan Lowther
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.